相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Network analysis, sequence and structure dynamics of key proteins of coronavirus and human host, and molecular docking of selected phytochemicals of nine medicinal plants
Toluwase Hezekiah Fatoki et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
QSAR Modeling of SARS-CoV MproInhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and Other Drugs as Candidates for Repurposing against SARS-CoV-2
Vinicius M. Alves et al.
MOLECULAR INFORMATICS (2021)
COVID-19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays
Xueqing Wang et al.
MEDICINAL RESEARCH REVIEWS (2021)
Review of registered clinical trials for the treatment of COVID-19
Fatemeh Babaei et al.
DRUG DEVELOPMENT RESEARCH (2021)
Open Targets Platform: supporting systematic drug-target identification and prioritisation
David Ochoa et al.
NUCLEIC ACIDS RESEARCH (2021)
Integrated network analysis reveals new genes suggesting COVID-19 chronic effects and treatment
Alisa Pavel et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Syncytia formation by SARS-CoV-2-infected cells (vol 39, e106267, 2020)
Julian Buchrieser et al.
EMBO JOURNAL (2021)
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia
Luca Braga et al.
NATURE (2021)
Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway
Andrea R. Daamen et al.
SCIENTIFIC REPORTS (2021)
Neutralizing monoclonal antibodies for COVID-19 treatment and prevention
Juan Pablo Jaworski
BIOMEDICAL JOURNAL (2021)
Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease
Alex J. B. Kreutzberger et al.
JOURNAL OF VIROLOGY (2021)
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2
Nir Drayman et al.
SCIENCE (2021)
Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19
Brian L. Le et al.
SCIENTIFIC REPORTS (2021)
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Petra Mlcochova et al.
NATURE (2021)
WADDAICA: A webserver for aiding protein drug design by artificial intelligence and classical algorithm
Qifeng Bai et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development
Miao-Miao Zhao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
A review on drug repurposing applicable to COVID-19
Serena Dotolo et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Antivirals for COVID-19: A critical review
Andri Frediansyah et al.
CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH (2021)
BMDx: a graphical Shiny application to perform Benchmark Dose analysis for transcriptomics data
Angela Serra et al.
BIOINFORMATICS (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
Toshio Hirano et al.
IMMUNITY (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
TinderMIX: Time-dose integrated modelling of toxicogenomics data
Angela Serra et al.
GIGASCIENCE (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
The COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19)
Maryam Rameshrad et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)
The first, holistic immunological model of COVID-19: Implications for prevention, diagnosis, and public health measures
Paolo Maria Matricardi et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2020)
Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?
Irene Karampela et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): a systematic review
William Gustavo Lima et al.
ARCHIVES OF VIROLOGY (2020)
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
Kamal S. Saini et al.
BRITISH JOURNAL OF CANCER (2020)
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Mehdi Bouhaddou et al.
CELL (2020)
Transcriptome-based drug repositioning for coronavirus disease 2019 (COVID-19)
Zhilong Jia et al.
PATHOGENS AND DISEASE (2020)
COVID-19 Therapeutic Options Under Investigation
Malak Kaddoura et al.
FRONTIERS IN PHARMACOLOGY (2020)
Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review
Shahamah Jomah et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19
Mark Roschewski et al.
SCIENCE IMMUNOLOGY (2020)
Coagulation disorders in coronavirus infected patients: COVID-19, SARS- CoV-1, MERS-CoV and lessons from the past
Dimitrios Giannis et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Repurposing of Kinase Inhibitors for Treatment of COVID-19
Ellen Weisberg et al.
PHARMACEUTICAL RESEARCH (2020)
Syncytia formation by SARS-CoV-2-infected cells
Julian Buchrieser et al.
EMBO JOURNAL (2020)
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
Franck Touret et al.
SCIENTIFIC REPORTS (2020)
Array programming with NumPy
Charles R. Harris et al.
NATURE (2020)
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Ludovico Cantuti-Castelvetri et al.
SCIENCE (2020)
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir
Steffen Jockusch et al.
SCIENTIFIC REPORTS (2020)
Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19
Paola Stolfi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection
Seyedeh Zahra Mousavi et al.
INFECTION GENETICS AND EVOLUTION (2020)
COVID-19 pneumonia and the appropriate use of antibiotics
Amy Sarah Ginsburg et al.
LANCET GLOBAL HEALTH (2020)
Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology
Rossana Bussani et al.
EBIOMEDICINE (2020)
Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients
Feifei Yan et al.
CELL DISCOVERY (2020)
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
Wentao Ni et al.
CRITICAL CARE (2020)
Repurposing Anti-Cancer Drugs for COVID-19 Treatment
Nicholas Borcherding et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
COVID-19 and coagulative axis: review of emerging aspects in a novel disease
Matilde Boccia et al.
MONALDI ARCHIVES FOR CHEST DISEASE (2020)
The DOT1L inhibitor Pinometostat decreases the host-response against infections: Considerations about its use in human therapy
Laura Marcos-Villar et al.
SCIENTIFIC REPORTS (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
INfORM: Inference of NetwOrk Response Modules
Veer Singh Marwah et al.
BIOINFORMATICS (2018)
Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors
Jeanne M. Sisk et al.
JOURNAL OF GENERAL VIROLOGY (2018)
Network-based approach to prediction and population-based validation of in silico drug repurposing
Feixiong Cheng et al.
NATURE COMMUNICATIONS (2018)
A review of network-based approaches to drug repositioning
Maryam Lotfi Shahreza et al.
BRIEFINGS IN BIOINFORMATICS (2018)
Mask R-CNN
Kaiming He et al.
2017 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV) (2017)
PubChem Substance and Compound databases
Sunghwan Kim et al.
NUCLEIC ACIDS RESEARCH (2016)
Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters
Yun-Kai Zhang et al.
SCIENTIFIC REPORTS (2016)
PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS
Jayme L. Dahlin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
TopKLists: a comprehensive R package for statistical inference, stochastic aggregation, and visualization of multiple omics ranked lists
Michael G. Schimek et al.
STATISTICAL APPLICATIONS IN GENETICS AND MOLECULAR BIOLOGY (2015)
Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?
David Bajusz et al.
JOURNAL OF CHEMINFORMATICS (2015)
TopKLists: a comprehensive R package for statistical inference, stochastic aggregation, and visualization of multiple omics ranked lists
Michael G. Schimek et al.
STATISTICAL APPLICATIONS IN GENETICS AND MOLECULAR BIOLOGY (2015)
Open TG-GATEs: a large-scale toxicogenomics database
Yoshinobu Igarashi et al.
NUCLEIC ACIDS RESEARCH (2015)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Hit Identification and Optimization in Virtual Screening: Practical Recommendations Based on a Critical Literature Analysis
Tian Zhu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Drug repositioning: a machine-learning approach through data integration
Francesco Napolitano et al.
JOURNAL OF CHEMINFORMATICS (2013)
ABC drug transporter and nuclear receptor expression in human cytotrophoblasts: Influence of spontaneous syncytialization and induction by glucocorticoids
S. Manceau et al.
PLACENTA (2012)
Differential expression in RNA-seq: A matter of depth
Sonia Tarazona et al.
GENOME RESEARCH (2011)
Differential expression analysis for sequence count data
Simon Anders et al.
GENOME BIOLOGY (2010)
Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt
Steffen Durinck et al.
NATURE PROTOCOLS (2009)
minet: A R/Bioconductor Package for Inferring Large Transcriptional Networks Using Mutual Information
Patrick E. Meyer et al.
BMC BIOINFORMATICS (2008)
BMDExpress: a software tool for the benchmark dose analyses of genomic data
Longlong Yang et al.
BMC GENOMICS (2007)
A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure
Russell S. Thomas et al.
TOXICOLOGICAL SCIENCES (2007)
Large-scale mapping and validation of Escherichia coli transcriptional regulation from a compendium of expression profiles
Jeremiah J. Faith et al.
PLOS BIOLOGY (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial
D Sampath et al.
BLOOD (2006)
DrugBank: a comprehensive resource for in silico drug discovery and exploration
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2006)
Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells
T Ziegler et al.
JOURNAL OF VIROLOGY (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis
S Durinck et al.
BIOINFORMATICS (2005)
The cyclin-dependent kinase inhibitor UCN-01 plus cisplatin in advanced solid tumors: A California cancer consortium phase I pharmacokinetic and molecular correlative trial
PN Lara et al.
CLINICAL CANCER RESEARCH (2005)
affy -: analysis of Affymetrix GeneChip data at the probe level
L Gautier et al.
BIOINFORMATICS (2004)
Summaries of affymetrix GeneChip probe level data
RA Irizarry et al.
NUCLEIC ACIDS RESEARCH (2003)
Greedy function approximation: A gradient boosting machine
JH Friedman
ANNALS OF STATISTICS (2001)
Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies
AM Senderowicz
LEUKEMIA (2001)
UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines
A Monks et al.
INVESTIGATIONAL NEW DRUGS (2000)
分享论文
